Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alcobra Ltd (NASDAQ:ADHD)

5.01
Delayed Data
As of Aug 26
 +0.03 / +0.60%
Today’s Change
3.15
Today|||52-Week Range
9.14
-20.22%
Year-to-Date
No recent news for Alcobra Ltd.

Today’s Trading

Previous close4.98
Today’s open5.02
Day’s range4.98 - 5.14
Volume41,202
Average volume (3 months)81,865
Market cap$138.1M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+62.50%
Earnings growth (this year)-8.44%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.99

Competitors

 Today’s
change
Today’s
% change
IMDZImmune Design Corp+0.29+4.42%
CORICorium International...-0.66-9.64%
FBIOFortress Biotech Inc+0.08+2.91%
EIGREiger BioPharmaceuti...-0.68-4.07%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateAugust 30, 2016
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$0.00
Annual profit (last year)-$19.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Yaron Daniely
Chief Operating Officer &
Chief Financial Officer
Tomer Berkovitz
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers

Search for Jobs